The four in vitro diagnostic kits, independently researched and developed by Well Biotech, officially received the registration certificate from the Jiangsu Medical Products Administration and are officially launched now!

The newly approved kits - Pepsinogen I/Pepsinogen II Combined Assay Kit, Full-range C-Reactive Protein (CRP) Assay Kit, Neutrophil Gelatinase-Associated Lipocalin (NGAL) Assay Kit, and Serum Amyloid A (SAA) Assay Kit – all utilize internationally advanced fluorescence immunochromatography technology, with a focus on “accuracy, speed, and convenience”, providing superior solutions for clinical diagnosis and health management. The approval of these four kits marks Well Biotech's comprehensive strategic layout in the fields of inflammatory infections, kidney diseases, and gastric function testing, delivering new clinical value.